SOFARMEX

Active

Private limited companyfounded 201610 yrs activeEmile Vanderveldelaan 82, 1200 Sint-Lambrechts-Woluwe, BelgiumKBO/BCE: BE 0654.747.129

SOFARMEX has been active since 2016 and the Belgian State Gazette contains no insolvency or warning signals. The 2026 annual accounts show equity of €4.50M and a net result of €2.45M. The figures fluctuate too strongly year-on-year for a reliable trend projection. The computed 12-month bankruptcy probability is 1.1% (low).

Watch Print / PDF

Checked score

Score 2026

88 / 100

Excellent

The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.

Axes · tick = 2025

Profitability100=

Solvency100=

Growth70▲+1

Track record100

Bankruptcy probability, 12 months

1.1% Low

0%0.5%1.5%4%10%≥ 25%

Credit up to €390k at 30 days acceptable

Liquidity ample (current ratio 7.09 against 4.83 in 2025; short-term debt: 14.1% of total assets), and 14.1% of the assets are financed with debt.

How do we compute the score and the probability?

Credit advice for your own amount and term

Signals

Seven signals. The signal on the left, the evidence on the right.

−lowers risk+raises risk○neutral

Higher-failure-rate region

In this region companies fail more often than in the rest of the country.

KBO · registered office

Annual accounts: healthy financial profile

The latest annual accounts show a healthy profile in solvency, result and liquidity.

NBB · annual accounts 2026

Solvency, return and age of the figures

Solvency

85.9%

Return on assets

46.9%

Age of the figures

8 mo

Multiple establishment units

Several establishment units mean more fixed costs, and such companies fail more often than a company with one establishment.

KBO · establishment units

Higher-failure-rate sector

In this sector companies fail more often than the Belgian average.

Gazette · bankruptcies per sector, NACE 21

Relative position

BE, all sectors

reference

Sector 21

higher

← fewer bankruptcies more bankruptcies →

Latest accounts filed on time

The financial year that closed on 31-01-2026 was due by 31-08-2026 and was filed on 30-06-2026, 62 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2026

62 d early

2025

55 d early

2024

52 d early

2023

14 d early

2022

20 d early

2021

44 d early

2020

9 d late

← before the deadline after the deadline →

The next deadline is still running

The next financial year closes on 31-01-2027 and is due by 31-08-2027. Nothing is late today.

Companies Code · seven months

Position in the running window

23-09-2026 today31-01-2027 close31-08-2027 deadline

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage

Financials · fiscal year 2026, full schema

Turnover

€30.04M▲ 9.8%

2025 · €27.36M

2019: €19.91M 2020: €16.03M 2021: €24.93M 2023: €23.54M 2024: €23.88M 2025: €27.36M

2019 → 2026

EBIT margin

10.8%▲ 1.2pp

2025 · 9.6%

2019: 3.6% 2020: 3.6% 2021: 9.6% 2023: 9.4% 2024: 9.3% 2025: 9.6%

2019 → 2026

Net result

€2.45M▲ 25.5%

2025 · €1.95M

2019: €473k 2020: €288k 2021: €1.85M 2023: €1.71M 2024: €1.72M 2025: €1.95M

2019 → 2026

Working capital

€4.50M▲ 120%

2025 · €2.04M

2019: €-2.58M 2020: €-1.26M 2021: €1.63M 2023: €67k 2024: €89k 2025: €2.04M

2019 → 2026

Multi-year overview

Every figure with its change against the year before

▲ rise ▼ fall

Line20212023202420252026Trend

Turnover€24.93M-€23.54M▼ 5.6%€23.88M▲ 1.5%€27.36M▲ 14.6%€30.04M▲ 9.8%

Equity€2.77M-€67k▼ 97.6%€89k▲ 31.5%€2.04M▲ 2,203%€4.50M▲ 120%

Operating result€2.40M-€2.22M▼ 7.6%€2.23M▲ 0.5%€2.63M▲ 18.2%€3.25M▲ 23.3%

Net result€1.85M-€1.71M▼ 7.5%€1.72M▲ 0.7%€1.95M▲ 13.6%€2.45M▲ 25.5%

Result per fiscal year

Operating resultNet result

The operating result has risen three years in a row; 2026 is 23% above 2025 and is the highest result in the available series.

Balance-sheet composition

2026 in colour, 2025 as the grey bar beneath

Equity and liabilities €5.23M

85.9%

14.1%

Equity €4.50M▲ 120%

Debt €739k▲ 38.6%

The debt ratio falls from 20.7% to 14.1%. Equity and debt are higher.

Key figures and ratios

2026 value · change against 2025

Solvency

85.9%▲

2025 · 79.3%

Current ratio

7.09▲

2025 · 4.83

Quick ratio

3.81▲

2025 · 3.62

Debt / equity

0.16▼

2025 · 0.26

ROE

54.6%▼

2025 · 95.7%

ROA

46.9%▼

2025 · 75.9%

Debt

€739k▲

2025 · €533k

Debt ≤ 1 year

€739k▲

2025 · €533k

Income taxes

€818k▲

2025 · €652k

Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.

Filed annual accounts

As filed with the NBB · 2026 against 2025

Balance sheet Code20252026

Assets

Total assets20/58€2.58M€5.23M▲

Current assets29/58€2.58M€5.23M▲

Stocks and contracts in progress3€648k€2.42M▲

Stocks30/36€648k€2.42M▲

Goods purchased for resale34€648k€2.42M▲

Amounts receivable within one year40/41€1.93M€2.82M▲

Trade receivables40€1.48M€628k▼

Other amounts receivable41€446k€2.19M▲

Equity and liabilities

Total equity and liabilities10/49€2.58M€5.23M▲

Equity10/15€2.04M€4.50M▲

Contributions10/11€19k€19k=

Reserves13€2k€2k=

Non-distributable reserves130/1€2k€2k=

Reserves not available under the articles1311€2k€2k=

Profit (loss) carried forward14€2.02M€4.48M▲

Amounts payable17/49€533k€739k▲

Amounts payable within one year42/48€533k€739k▲

Trade debts44€433k€739k▲

Suppliers440/4€433k€739k▲

Other amounts payable47/48€100k-

Income statement Code20252026

Operating income70/76A€27.36M€30.04M▲

Turnover70€27.36M€30.04M▲

Operating charges60/66A€24.73M€26.79M▲

Goods for resale, raw materials and consumables60€22.59M€24.37M▲

Purchases600/8€23.17M€26.16M▲

Change in stocks: decrease (increase)609€-583k€-1.79M▼

Services and other goods61€2.10M€2.40M▲

Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4€34k€19k▼

Other operating charges640/8€1k€1k▲

Operating profit (loss)9901€2.63M€3.25M▲

Financial income75/76B€4k€24k▲

Recurring financial income75€4k€24k▲

Income from financial fixed assets750€3k€24k▲

Other financial income752/9€1k€532▼

Non-recurring financial income76B€13-

Financial charges65/66B€32k€2k▼

Recurring financial charges65€32k€2k▼

Debt charges650€32k€2k▼

Non-recurring financial charges66B€91€15▼

Profit (loss) for the period before taxes9903€2.61M€3.27M▲

Income taxes67/77€652k€818k▲

Taxes670/3€652k€818k▲

Profit (loss) for the period9904€1.95M€2.45M▲

Profit (loss) for the period to be appropriated9905€1.95M€2.45M▲

Appropriation of the result

Profit (loss) to be appropriated9906€2.02M€4.48M▲

Profit (loss) brought forward from the previous period14P€68k€2.02M▲

The notes to these accounts (21 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

All 18Financial 6Gazette 2Filings 10

Next filing, fiscal year 2027, expected by 31-08-2027

2026

03-09

State Gazette act Resignations & appointments

General meeting · Director reappointment · Mandate compensation3 facts ▸

General meeting, 2026-06-25
Director reappointment, Arnaud Berken (administrateur)
Mandate compensation, Arnaud Berken

03-09

State Gazette act Resignations & appointments

General meeting · Director reappointment · Mandate compensation3 facts ▸

General meeting, 2026-06-25
Director reappointment, Arnaud Berken (bestuurder)
Mandate compensation, Arnaud Berken

30-06

NBB filing Annual accounts filed

fiscal year 2026 · full schema

31-01

Financial Highest result since 2019net €2.45M ▲25.5%

Operating result €3.25M, net result €2.45M, both a record.

2025

07-07

NBB filing Annual accounts filed

fiscal year 2025 · unclassified schema

31-01

Financial Liquidity times 5current ratio 4.83

Current ratio from 1.02 to 4.83; short-term debt falls from €4.19M to €533k.

31-01

Financial Equity above €2MEq €2.04M ▲2203%

6 profitable years in a row build equity to €2.04M.

2024

10-07

NBB filing Annual accounts filed

fiscal year 2024 · unclassified schema

2023

17-10

NBB filing Annual accounts filed

fiscal year 2023 · unclassified schema

2022

11-10

NBB filing Annual accounts filed

fiscal year 2022 · unclassified schema

2021

17-09

NBB filing Annual accounts filed

fiscal year 2021 · unclassified schema

31-03

Financial Liquidity times 5current ratio 3.48

Current ratio from 0.66 to 3.48; short-term debt falls from €3.75M to €658k.

31-03

Financial Equity above €2MEq €2.77M ▲200%

3 profitable years in a row build equity to €2.77M.

2020

09-11

NBB filing Annual accounts filed

fiscal year 2020 · full schema · 9 days late

31-03

Financial Weakest financial yearnet €288k ▼39%

Net result drops to €288k, the lowest in the series; recovery starts the following year.

2019

30-09

NBB filing Annual accounts filed

fiscal year 2019 · full schema

2018

12-10

NBB filing Annual accounts filed

fiscal year 2018 · full schema

2017

20-10

NBB filing Annual accounts filed

fiscal year 2017 · full schema

Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors

1 director, no change since 2026

Arnaud Berken

Director · since 25-06-2026

Current

25-06-2026 Mandate renewed as Director

Location & real-estate footprint

Registered office, Sint-Lambrechts-Woluwe · 2 establishment units since 2016

establishment All 2 establishment units on the map

Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Emile Vanderveldelaan 821200 Sint-Lambrechts-Woluwe

Ground area

4.2 ha

Building footprint

189 m²

Volume, LiDAR

657 m³

3 parcels, Brussels, Flanders, Wallonia · tallest building 9.3 m, ±2 floors. Linked by address, not a title deed.

2 establishment units

SOFARMEX

Marthe Versichelenstraat 1, 9052 GentManufacture of chemicals and chemical products

since 20162.258.031.920

SOFARMEX

Chemin de la Reconversion(H-G) 11, 7110 La LouvièreManufacture of chemicals and chemical products

since 20192.292.641.124

3 parcels

Flanders 1 (33.3%) Wallonia 1 (33.3%) Brussels 1 (33.3%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
55020C0043/00G000	Wallonia	3.4 ha	-	-
44082B0643/00F000	Flanders	7,611 m²	1 · 75 m²	3.1 m
21018B0104/00R014	Brussels	250 m²	1 · 114 m²	9.3 m · 2 fl.

Linked by address, not proof of ownership

Methodology

via registered seat: 1 · via establishment units: 2

3 of 3 parcels with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

KCI Polymedics

BE 0452.683.261

Peer · Eq €4.57M

DIAsource ImmunoAssays S.A.

BE 0457.934.723

Ottignies-Louvain-la-Neuve · Eq €4.41M

Marche-en-Famenne · Eq €4.87M

LAMBO Laboratoria - LAMBO Laboratoires

BE 0404.094.872

Wijnegem · Eq €5.30M

Of 97 companies in sector 21209 we hold annual accounts for 74. 38 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification

Legal formPrivate limited company

Founded17-05-2016

Fiscal year end31-01

Activities, NACEBEL

21209Manufacture of basic pharmaceutical products and pharmaceutical preparations

21201Manufacture of basic pharmaceutical products and pharmaceutical preparations

Sources

Crossroads Bank for EnterprisesNational Bank · 10 filingsAddress and cadastre registers

Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.